Dr Jennifer Young is a radiochemist at Barts Cancer Institute, Queen Mary University of London, specialising in developing and translating novel radiopharmaceuticals for cancer treatment. Since 2021, she has led the Radionuclides for Health UK initiative, championing improved access to essential medical radionuclides and fostering collaboration across the sector. Jennifer has also undertaken secondments with government policy teams at the Department of Health and Social Care and the Department for Energy Security and Net Zero.